Cellectar Biosciences
(NASDAQ:CLRB)
$3.29
-0.22[-6.27%]
At close: Apr 15
$3.29
0[0.00%]
After Hours: 4:28PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Cellectar Biosciences Stock (NASDAQ:CLRB), Quotes and News Summary

Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.

Open$3.510
Close$3.320
Volume / Avg.842.897K / 1.190M
Day Range3.280 - 3.540
52 Wk Range1.330 - 4.450
Market Cap$106.137M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest
7.86%
Days to Cover1.95

Recent News

Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why
Cellectar Biosciences reports positive Phase 1 trial results for iopofosine I 131 in head and neck squamous cell carcinoma, achieving 64% complete remission and 73% overall response rate. Roth Capital notes the drug's potential across various diseases, positioning CLRB as an attractive acquisition target.
Vandana Singh
Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today?
Cellectar Biosciences Inc (NASDAQ: CLRB) announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a targeted radiotherapy candidate for the treatment of relapsed/refractory Waldenstrom's macroglobulinemia (WM) patients that have received at 
Vandana Singh
Crude Oil Rises 1%; Verb Technology Shares Spike Higher
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling 100 points on Tuesday. The Dow traded down 0.31% to 34,728.66 while the NASDAQ rose 0.11% to 14,047.61. The S&P 500, also fell, dropping, 0.22% to 4,505.65.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
3
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Cellectar Biosciences Inc
Sector
Health Care
Industry
Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discov...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CLRB
MOLN

FAQ

Q

How do I buy Cellectar Biosciences (CLRB) stock?

A

You can purchase shares of Cellectar Biosciences (NASDAQ: CLRB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cellectar Biosciences's (CLRB) competitors?

A

Other companies in Cellectar Biosciences’s space includes: Molecular Partners (NASDAQ:MOLN), Anixa Biosciences (NASDAQ:ANIX), Connect Biopharma Hldgs (NASDAQ:CNTB), FibroGen (NASDAQ:FGEN) and Barinthus Biotherapeutics (NASDAQ:BRNS).

Q

What is the target price for Cellectar Biosciences (CLRB) stock?

A

The latest price target for Cellectar Biosciences (NASDAQ: CLRB) was reported by Roth MKM on Thursday, March 28, 2024. The analyst firm set a price target for 28.00 expecting CLRB to rise to within 12 months (a possible 751.06% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cellectar Biosciences (CLRB)?

A

The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $3.29 last updated April 15, 2024 at 4:28 PM EDT.

Q

Does Cellectar Biosciences (CLRB) pay a dividend?

A

There are no upcoming dividends for Cellectar Biosciences.

Q

When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?

A

Cellectar Biosciences’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Cellectar Biosciences (CLRB) going to split?

A

There is no upcoming split for Cellectar Biosciences.

Q

What sector and industry does Cellectar Biosciences (CLRB) operate in?

A

Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch